GPT Healthcare Ltd
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]
- Market Cap ₹ 1,130 Cr.
- Current Price ₹ 138
- High / Low ₹ 185 / 114
- Stock P/E 27.1
- Book Value ₹
- Dividend Yield 1.81 %
- ROCE 23.6 %
- ROE 28.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 53.9%
Cons
- Promoter holding has decreased over last 3 years: -34.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| 212 | 243 | 337 | |
| 176 | 194 | 263 | |
| Operating Profit | 36 | 49 | 74 |
| OPM % | 17% | 20% | 22% |
| 4 | 6 | 5 | |
| Interest | 14 | 14 | 11 |
| Depreciation | 11 | 12 | 14 |
| Profit before tax | 15 | 29 | 54 |
| Tax % | 26% | 27% | 23% |
| 11 | 21 | 42 | |
| EPS in Rs | 6.11 | 11.76 | 5.22 |
| Dividend Payout % | 0% | 47% | 115% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 102% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 18% |
| Last Year: | 29% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| Equity Capital | 18 | 18 | 80 |
| Reserves | 109 | 116 | 78 |
| 157 | 166 | 96 | |
| 25 | 18 | 70 | |
| Total Liabilities | 308 | 317 | 323 |
| 226 | 220 | 220 | |
| CWIP | 2 | 0 | 1 |
| Investments | 1 | 1 | 10 |
| 80 | 97 | 92 | |
| Total Assets | 308 | 317 | 323 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| 41 | 43 | 66 | |
| -54 | -16 | -5 | |
| 12 | -22 | -57 | |
| Net Cash Flow | -1 | 4 | 3 |
| Free Cash Flow | -5 | 38 | 59 |
| CFO/OP | 116% | 88% | 107% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| Debtor Days | 30 | 26 | 15 |
| Inventory Days | 60 | 41 | 30 |
| Days Payable | 314 | 165 | 121 |
| Cash Conversion Cycle | -224 | -98 | -76 |
| Working Capital Days | -4 | 32 | 3 |
| ROCE % | 14% | 24% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Number of Beds (Capacity) Number |
|
|||||
| Average Length of Stay (ALOS) Days |
||||||
| Average Revenue per Occupied Bed (ARPOB) INR |
||||||
| Inpatient Volume Number |
||||||
| Occupancy Rate % |
||||||
| Outpatient Volume Number |
||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; no demat/remat requests received.
-
Announcement under Regulation 30 (LODR)-Change in Management
2 Apr - Debashis Dhar resigned as Senior VP and Chief Business Development Officer, effective April 2, 2026.
- Closure of Trading Window 26 Mar
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 Mar - For Investor Meet on Tuesday, March 10, 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 Mar - For Investor meet on Friday, February 6, 2026.
Concalls
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Mar 2024Transcript PPT
Business Overview:[1]
GPT Healthcare Limited operates as a key regional corporate healthcare provider in Eastern India under the ILS Hospitals brand. The organization has established 5 multi-specialty hospitals with a total capacity of 719 beds, supported by 91 full-time consultants and 630 visiting consultants.